期刊文献+

结直肠癌^18F—FDGPET/CT代谢参数与肝转移的关系 被引量:1

Relationship between ^18F-FDG PET/CT metabolic parameters and fiver metastasis from colorectal cancer
原文传递
导出
摘要 目的探讨结直肠癌(CRC)原发灶18F-脱氧葡萄糖(FDG) PET/CT代谢参数与肝转移的关系。方法回顾性分析2012年1月至2016年10月间在上海市仁济医院核医学科行18F-FDG PET/CT检查的98例CRC患者资料[男66例、女32例,年龄(64±13)岁],所有患者均在术前行PET/CT检查,检查前未行任何治疗,对CRC患者的临床病理因素以及PET/CT肿瘤代谢参数与肝转移的关系进行分析。采用χ^2=验和logistic回归分析数据。结果98例CRC患者中,无肝转移者78例,有肝转移者20例。单因素分析结果显示,无肝转移组和有肝转移组患者在肿瘤位置(χ^2=5.983)、T分期(χ^2=6.447)、血清癌胚抗原(CEA)水平(χ^2=5.501)、肿瘤代谢体积(MTV; χ^2=6.282)、病灶糖酵解总量(TLG; χ^2=9.046)上差异均有统计学意义(均P〈0.05);多因素分析结果显示,肿瘤位置、T分期、血清CEA水平、MTV、TLG[比值比(OR):0.059~7.575]均是CRC肝转移的独立危险因素,且MTV、TLG和肝转移呈负相关。结论CRC肿瘤位置、T分期、血清CEA水平以及原发灶PET/CT代谢参数MTV和TLG均是CRC肝转移的独立危险因素,且MTV、TLG和肝转移呈负相关。 ObjectiveTo investigate the relationship between 18F-fluorodeoxyglucose (FDG) PET/CT metabolic parameters of colorectal cancer (CRC) and liver metastasis.MethodsA total of 98 CRC patients (66 males, 32 females, average age: (64±13) years) from January 2012 to October 2016 in Shanghai Renji Hospital were enrolled in this retrospective study. All patients underwent 18F-FDG PET/CT and had not received any treatment before surgery. The relationships between clinical pathological results, metabolic parameters and liver metastasis were analyzed. Data were analyzed using χ^2=test and logistic regression analysis.ResultsPatients were divided into two groups, 78 without liver metastasis, 20 with liver metastasis. Univariate analysis showed that the tumor primary location(χ^2=5.983), T stage(χ^2=6.447), serum carcinoembryonic antigen (CEA) levels(χ^2=5.501), metabolic tumor volume (MTV; χ^2=6.282) and total lesion glycolysis (TLG; χ^2=9.046) were significantly different between the two groups (all P〈0.05). Multiple factor analysis showed that the tumor primary location, T stage, serum CEA levels, MTV and TLG (odds ratio (OR): 0.059-7.575)were independent risk factors of CRC liver metastasis, and MTV and TLG were negatively correlated with liver metastasis.ConclusionsTumor primary location, T stage, serum CEA levels, MTV and TLG are independent risk factors of CRC liver metastasis. MTV and TLG are negatively correlated with liver metastasis.
作者 严卉 陈虞梅 贾文芝 黄钢 刘建军 Yah Hui;Chen Yumei;Jia Wenzhi;Huang Gang;Liu Jianjun(Department of Nuclear Medicine,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shang-hai 200127,China)
出处 《中华核医学与分子影像杂志》 CAS 北大核心 2018年第7期485-488,共4页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 国家自然科学基金(81471687)
关键词 结直肠肿瘤 肿瘤转移 正电子发射断层显像术 体层摄影术 X线计算机 脱氧葡萄糖 Colorectal neoplasms Neoplasm metastasis Liver Positron-emission tomography Tomography X-ray computed Deoxyglucose
  • 相关文献

参考文献3

二级参考文献43

  • 1王荣福,杨熊飞,张春丽,张建华,张旭初,付占立,范岩,胡怀湘,王彦福,田红,郭凤琴,徐文怀.符合线路显像在大肠癌术后复发转移中的临床应用[J].中华核医学杂志,2004,24(4):210-212. 被引量:5
  • 2万卫星,尤徐阳,陆燕君,郁春景,王芳军.^(18)F-FDG符合线路显像在卵巢上皮性癌术后监测中的价值[J].中华核医学杂志,2005,25(5):270-273. 被引量:5
  • 3蔡莉,高硕,李彦生,李大成,邢喜玲.^(18)F-FDG与^(11)C-MET PET显像在神经上皮性肿瘤术前分级中的价值及与Ki67相关性的比较[J].中华核医学杂志,2006,26(1):8-12. 被引量:10
  • 4Zubeldia JM, Bednarczyk EM, Baker JG, et al. The economic impact of 18 FDG positron emission tomography in the surgical management of colorectal cancer wlth hepatic metastases. Cancer Biother Radiophaml, 2005, 20: 450-456.
  • 5Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated 18F-fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol, 2005, 23: 7654-7659.
  • 6Zervos EE, Badgwell BD, Burak WE, et al. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup. Surgery, 2001, 130: 636-644.
  • 7Flamen P, Hoekstra OS, Homans F, et al. Unexplained rising car- cinoembryonic antigen ( CEA ) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer, 2001, 37 : 862-869.
  • 8Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol, 1995, 21 : 517-522.
  • 9Lonneux M, Reffad AM, Detry R, et al. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. EurJ Nucl Med Mnl Imaging, 2002, 29: 915-921.
  • 10Engd H, Steinert H, Buck A, el al. Whole-body PET:physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med, 1996, 37 : 441-446.

共引文献21

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部